Better Drugs, New Targets and Lower Toxicity in Lung Cancer Treatment | Transcript | Lung Cancer | Patient Power


Are Some Metastatic Lung Cancer Patients Outliving Prognosis?

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you. 

Dr. Carbone:

There's a lot of research that's coming out every week, every month right now that will directly impact the quality and quantity of life of lung cancer patients.  It's new drugs that are better than the old ones at targeting genetic abnormalities, drugs that are targeting new genetic abnormalities, and drugs that have lower toxicity, longer efficacy, better penetration into the brain to affect patients with brain metastases or even prevent them from getting brain metastases.  So that's a very exciting aspect of targeted therapy development right now. 

But I think the newest development which is very exciting to all of us is the immunotherapy progress, and that has shown efficacy now even as the first treatment that lung cancer patients get instead of chemotherapy.  And there are patients from early trials with these drugs that still have a sustained, complete remission without ever seeing chemotherapy now five, six, seven, eight, years after their diagnosis.  

And this is incredibly exciting to me, that there could be a subset of patients with advanced metastatic lung cancer who have a short course of therapy with a minimally toxic drug that causes a complete remission that lasts for years, and this is transformational. 

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you. 

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on April 5, 2017